Grifols, S.A. : Back on key levels based on weekly price data
| Entry price | Target | Stop-loss | Potential |
|---|
|
€26.3 |
€30 |
€24.4 |
+14.07% |
|---|
Grifols, S.A. shares are sitting close to an important technical support area around 18.13 USD based on weekly price data. Against this backdrop, investors can use this good timing for new long positions.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at EUR 26.01 EUR in weekly data.
● Graphically speaking, the timing seems perfect for purchasing the stock close to the EUR 24.59 support.
● The company returns high margins, thereby supporting business profitability.
● Considering the small differences between the analysts' various estimates, the group's business visibility is good.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
● One of the major weak points of the company is its financial situation.
● With an enterprise value anticipated at 4.41 times the sales for the current fiscal year, the company turns out to be overvalued.
● The company is not the most generous with respect to shareholders' compensation.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
